+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Undenatured Type II Collagen Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 198 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6117329
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Undenatured type II collagen is reshaping the joint health and inflammatory therapeutic landscape, offering novel opportunities for nutraceutical developers and clinical stakeholders. Its distinctive molecular form supports advanced immunomodulatory benefits and is gaining traction among manufacturers seeking to meet evolving market and regulatory demands.

Market Snapshot: Undenatured Type II Collagen

The global market for undenatured type II collagen is experiencing accelerated expansion, propelled by advancements in extraction technologies and an increasing demand for natural joint health solutions. Heightened patient awareness, coupled with regulatory clarification around collagen-based therapeutics, is enabling broader industry participation and investment from manufacturers and research organizations. Adoption is particularly strong in regions prioritizing preventive healthcare and alternative therapies, with digital platforms supporting product visibility and consumer education. Market players are responding by diversifying sourcing channels and optimizing distribution to capitalize on emerging demographic trends and shifting healthcare practices.

Scope & Segmentation

This comprehensive report examines market trends, demand patterns, and strategic activities across major categories. Key areas of analysis include:

  • End Use: Nutraceuticals (dietary supplements, functional food), pharmaceuticals (OTC drugs, prescription drugs), and research institutes (academic research, clinical trials).
  • Source: Bovine, chicken, fish (cod, salmon, tilapia), and porcine origins.
  • Form: Capsule, liquid, powder (bulk powder, microencapsulated powder), and tablet.
  • Application: Osteoarthritis and rheumatoid arthritis.
  • Distribution Channel: Hospital pharmacy, modern trade, online pharmacy (direct to consumer, third party platforms), retail pharmacy, specialty stores.
  • Dosage: 40-80 mg, less than 40 mg, greater than 80 mg (80-120 mg, above 120 mg).
  • Regions: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, and others), and Asia-Pacific (China, India, Japan, Australia, and other leading nations).
  • Key Companies: InterHealth Nutraceuticals LLC, Bioiberica SA, Gelita AG, Darling Ingredients Inc., SanMyo BioScience Pvt. Ltd., Zhejiang Garden Biochemical High-Tech Co., Ltd., Suzhou Jinda Biological Engineering Co., Ltd., Hebei Haobo Biological Technology Co., Ltd., Fortune Bioproducts Co., Ltd., Advanced Protein Technologies Pte Ltd.

Key Takeaways for Senior Decision-Makers

  • Breakthroughs in enzymatic extraction have improved purity and preserved the functional triple helix, reinforcing the market relevance of undenatured type II collagen.
  • Rising consumer inclination toward natural, non-pharmacological joint care has driven product innovation and spurred collaborations between nutraceutical manufacturers and academic researchers.
  • Regulatory clarity in major markets is supporting standardized quality assurance, enabling smoother integration of undenatured type II collagen into diverse product portfolios.
  • Integration of digital health platforms and supply chain management tools has increased transparency, supporting robust real-world evidence collection and quicker response to regulatory shifts.
  • Regional strategies now emphasize localized sourcing, tailored formulations, and digitally enabled distribution networks to address specific consumer and regulatory environments.

Tariff Impact on Supply Chains and Market Strategy

With United States tariffs impacting the sector from 2025, supply chain adjustments are in focus. Raw material exporters face complex sourcing calculations, motivating manufacturers to consider alternative suppliers or domestic partnerships. Improved inventory management and agile distribution are necessary to address extended lead times. Research entities are diversifying suppliers and leveraging digital tracking to ensure supply stability, leading to more resilient and collaboratively managed ecosystems.

SEO & Technology: Primary Keyword Integration

Undenatured type II collagen remains the central focus, underpinning both clinical and commercial advances across nutraceutical and pharmaceutical industries.

Methodology & Data Sources

The findings in this report derive from a multi-phase research process, including a thorough literature review, expert interviews, and structured stakeholder surveys. Triangulation with market intelligence databases and statistical analysis ensures every insight is reliable and reflective of real-world market dynamics.

Why This Report Matters

  • Enables decision-makers to clearly identify opportunities and risks within the undenatured type II collagen value chain, facilitating strategic portfolio alignment.
  • Offers a comprehensive understanding of the segment drivers, technology trends, and evolving regional regulations that inform long-term operational planning.
  • Supports actionable investment decisions through up-to-date, evidence-backed insights into product acceptance and emerging market structures.

Conclusion

Senior leaders leveraging this report will gain a cohesive perspective to guide strategic planning, optimize operational resilience, and capture growth potential as market adoption of undenatured type II collagen accelerates.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising consumer demand for joint health supplements with clinically validated undenatured type II collagen as alternative to glucosamine sulfate supplementation
5.2. Expansion of sports nutrition products incorporating undenatured type II collagen to support recovery and performance in active athletes
5.3. Growth of premium pet care segment leveraging undenatured type II collagen for canine joint mobility and arthritis prevention
5.4. Integration of undenatured type II collagen in combination nutraceutical formulations with hyaluronic acid and MSM for synergistic joint health benefits
5.5. Surge in direct-to-consumer subscription models offering personalized undenatured type II collagen dosage plans based on genetic and lifestyle data
5.6. Regulatory harmonization efforts and emerging global quality standards shaping supply chain transparency for undenatured type II collagen supplements
5.7. Development of novel delivery formats such as gummies and effervescent tablets to improve consumer compliance with undenatured type II collagen intake
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Undenatured Type II Collagen Market, by End Use
8.1. Introduction
8.2. Nutraceuticals
8.2.1. Dietary Supplements
8.2.2. Functional Food
8.3. Pharmaceuticals
8.3.1. Otc Drugs
8.3.2. Prescription Drugs
8.4. Research Institutes
8.4.1. Academic Research
8.4.2. Clinical Trials
9. Undenatured Type II Collagen Market, by Source
9.1. Introduction
9.2. Bovine
9.3. Chicken
9.4. Fish
9.4.1. Cod
9.4.2. Salmon
9.4.3. Tilapia
9.5. Porcine
10. Undenatured Type II Collagen Market, by Form
10.1. Introduction
10.2. Capsule
10.3. Liquid
10.4. Powder
10.4.1. Bulk Powder
10.4.2. Microencapsulated Powder
10.5. Tablet
11. Undenatured Type II Collagen Market, by Application
11.1. Introduction
11.2. Osteoarthritis
11.3. Rheumatoid Arthritis
12. Undenatured Type II Collagen Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacy
12.3. Modern Trade
12.4. Online Pharmacy
12.4.1. Direct To Consumer
12.4.2. Third Party Platforms
12.5. Retail Pharmacy
12.6. Specialty Stores
13. Undenatured Type II Collagen Market, by Dosage
13.1. Introduction
13.2. 40-80 mg
13.3. < 40 mg
13.4. >80 mg
13.4.1. 80-120 mg
13.4.2. >120 mg
14. Americas Undenatured Type II Collagen Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Undenatured Type II Collagen Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Undenatured Type II Collagen Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. InterHealth Nutraceuticals LLC
17.3.2. Bioiberica SA
17.3.3. Gelita AG
17.3.4. Darling Ingredients Inc.
17.3.5. SanMyo BioScience Pvt. Ltd.
17.3.6. Zhejiang Garden Biochemical High-Tech Co., Ltd.
17.3.7. Suzhou Jinda Biological Engineering Co., Ltd.
17.3.8. Hebei Haobo Biological Technology Co., Ltd.
17.3.9. Fortune Bioproducts Co., Ltd.
17.3.10. Advanced Protein Technologies Pte Ltd.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. UNDENATURED TYPE II COLLAGEN MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY END USE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY END USE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY SOURCE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY FORM, 2024 VS 2030 (%)
FIGURE 10. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY DOSAGE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY DOSAGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. UNDENATURED TYPE II COLLAGEN MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. UNDENATURED TYPE II COLLAGEN MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. UNDENATURED TYPE II COLLAGEN MARKET: RESEARCHAI
FIGURE 28. UNDENATURED TYPE II COLLAGEN MARKET: RESEARCHSTATISTICS
FIGURE 29. UNDENATURED TYPE II COLLAGEN MARKET: RESEARCHCONTACTS
FIGURE 30. UNDENATURED TYPE II COLLAGEN MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. UNDENATURED TYPE II COLLAGEN MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY NUTRACEUTICALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY NUTRACEUTICALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY FUNCTIONAL FOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY FUNCTIONAL FOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY NUTRACEUTICALS, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY NUTRACEUTICALS, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY OTC DRUGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY OTC DRUGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY BOVINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY BOVINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY CHICKEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY CHICKEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY FISH, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY FISH, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY COD, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY COD, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY SALMON, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY SALMON, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY TILAPIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY TILAPIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY FISH, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY FISH, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY PORCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY PORCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY CAPSULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY CAPSULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY LIQUID, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY BULK POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY BULK POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY MICROENCAPSULATED POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY MICROENCAPSULATED POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY POWDER, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY POWDER, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY OSTEOARTHRITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY OSTEOARTHRITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY MODERN TRADE, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY MODERN TRADE, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY DIRECT TO CONSUMER, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY DIRECT TO CONSUMER, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY THIRD PARTY PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY THIRD PARTY PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY SPECIALTY STORES, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY SPECIALTY STORES, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY 40-80 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY 40-80 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY < 40 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY < 40 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY >80 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY >80 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY 80-120 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY 80-120 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY >120 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY >120 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY >80 MG, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY >80 MG, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY NUTRACEUTICALS, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY NUTRACEUTICALS, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY FISH, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY FISH, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY POWDER, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY POWDER, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY >80 MG, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY >80 MG, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY NUTRACEUTICALS, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY NUTRACEUTICALS, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY FISH, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY FISH, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY POWDER, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY POWDER, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY >80 MG, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY >80 MG, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 163. CANADA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 164. CANADA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 165. CANADA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY NUTRACEUTICALS, 2018-2024 (USD MILLION)
TABLE 166. CANADA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY NUTRACEUTICALS, 2025-2030 (USD MILLION)
TABLE 167. CANADA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 168. CANADA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 169. CANADA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 170. CANADA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 171. CANADA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 172. CANADA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 173. CANADA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY FISH, 2018-2024 (USD MILLION)
TABLE 174. CANADA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY FISH, 2025-2030 (USD MILLION)
TABLE 175. CANADA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 176. CANADA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 177. CANADA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY POWDER, 2018-2024 (USD MILLION)
TABLE 178. CANADA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY POWDER, 2025-2030 (USD MILLION)
TABLE 179. CANADA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 180. CANADA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 181. CANADA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 182. CANADA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 183. CANADA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 184. CANADA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 185. CANADA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 186. CANADA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 187. CANADA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY >80 MG, 2018-2024 (USD MILLION)
TABLE 188. CANADA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY >80 MG, 2025-2030 (USD MILLION)
TABLE 189. MEXICO UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 190. MEXICO UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 191. MEXICO UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY NUTRACEUTICALS, 2018-2024 (USD MILLION)
TABLE 192. MEXICO UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY NUTRACEUTICALS, 2025-2030 (USD MILLION)
TABLE 193. MEXICO UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 194. MEXICO UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 195. MEXICO UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 196. MEXICO UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 197. MEXICO UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 198. MEXICO UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 199. MEXICO UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY FISH, 2018-2024 (USD MILLION)
TABLE 200. MEXICO UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY FISH, 2025-2030 (USD MILLION)
TABLE 201. MEXICO UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 202. MEXICO UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 203. MEXICO UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY POWDER, 2018-2024 (USD MILLION)
TABLE 204. MEXICO UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY POWDER, 2025-2030 (USD MILLION)
TABLE 205. MEXICO UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 206. MEXICO UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 207. MEXICO UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 208. MEXICO UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 209. MEXICO UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 210. MEXICO UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 211. MEXICO UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 212. MEXICO UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 213. MEXICO UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY >80 MG, 2018-2024 (USD MILLION)
TABLE 214. MEXICO UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY >80 MG, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY NUTRACEUTICALS, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY NUTRACEUTICALS, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY FISH, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY FISH, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 229. BRAZIL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY POWDER, 2018-2024 (USD MILLION)
TABLE 230. BRAZIL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY POWDER, 2025-2030 (USD MILLION)
TABLE 231. BRAZIL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 232. BRAZIL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 233. BRAZIL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 234. BRAZIL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 235. BRAZIL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 236. BRAZIL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 237. BRAZIL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 238. BRAZIL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 239. BRAZIL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY >80 MG, 2018-2024 (USD MILLION)
TABLE 240. BRAZIL UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY >80 MG, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY NUTRACEUTICALS, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY NUTRACEUTICALS, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 247. ARGENTINA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 248. ARGENTINA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 251. ARGENTINA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY FISH, 2018-2024 (USD MILLION)
TABLE 252. ARGENTINA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY FISH, 2025-2030 (USD MILLION)
TABLE 253. ARGENTINA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 254. ARGENTINA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 255. ARGENTINA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY POWDER, 2018-2024 (USD MILLION)
TABLE 256. ARGENTINA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY POWDER, 2025-2030 (USD MILLION)
TABLE 257. ARGENTINA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 258. ARGENTINA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 259. ARGENTINA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 260. ARGENTINA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 261. ARGENTINA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 262. ARGENTINA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 263. ARGENTINA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 264. ARGENTINA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 265. ARGENTINA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY >80 MG, 2018-2024 (USD MILLION)
TABLE 266. ARGENTINA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY >80 MG, 2025-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY NUTRACEUTICALS, 2018-2024 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY NUTRACEUTICALS, 2025-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY FISH, 2018-2024 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY FISH, 2025-2030 (USD MILLION)
TABLE 279. EUROPE, MIDDLE EAST & AFRICA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 280. EUROPE, MIDDLE EAST & AFRICA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 281. EUROPE, MIDDLE EAST & AFRICA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY POWDER, 2018-2024 (USD MILLION)
TABLE 282. EUROPE, MIDDLE EAST & AFRICA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY POWDER, 2025-2030 (USD MILLION)
TABLE 283. EUROPE, MIDDLE EAST & AFRICA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 284. EUROPE, MIDDLE EAST & AFRICA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 285. EUROPE, MIDDLE EAST & AFRICA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 286. EUROPE, MIDDLE EAST & AFRICA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 289. EUROPE, MIDDLE EAST & AFRICA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 290. EUROPE, MIDDLE EAST & AFRICA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 291. EUROPE, MIDDLE EAST & AFRICA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY >80 MG, 2018-2024 (USD MILLION)
TABLE 292. EUROPE, MIDDLE EAST & AFRICA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY >80 MG, 2025-2030 (USD MILLION)
TABLE 293. EUROPE, MIDDLE EAST & AFRICA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 294. EUROPE, MIDDLE EAST & AFRICA UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 295. UNITED KINGDOM UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 296. UNITED KINGDOM UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 297. UNITED KINGDOM UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY NUTRACEUTICALS, 2018-2024 (USD MILLION)
TABLE 298. UNITED KINGDOM UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY NUTRACEUTICALS, 2025-2030 (USD MILLION)
TABLE 299. UNITED KINGDOM UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 300. UNITED KINGDOM UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 301. UNITED KINGDOM UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 302. UNITED KINGDOM UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 303. UNITED KINGDOM UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 304. UNITED KINGDOM UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 305. UNITED KINGDOM UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY FISH, 2018-2024 (USD MILLION)
TABLE 306. UNITED KINGDOM UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY FISH, 2025-2030 (USD MILLION)
TABLE 307. UNITED KINGDOM UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 308. UNITED KINGDOM UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 309. UNITED KINGDOM UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY POWDER, 2018-2024 (USD MILLION)
TABLE 310. UNITED KINGDOM UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY POWDER, 2025-2030 (USD MILLION)
TABLE 311. UNITED KINGDOM UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 312. UNITED KINGDOM UNDENATURED TYPE II COLLAGEN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 313. UNITED KINGDOM UNDENATURED TYPE II COLLAGEN MARKET SIZE, B

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Undenatured Type II Collagen market report include:
  • InterHealth Nutraceuticals LLC
  • Bioiberica SA
  • Gelita AG
  • Darling Ingredients Inc.
  • SanMyo BioScience Pvt. Ltd.
  • Zhejiang Garden Biochemical High-Tech Co., Ltd.
  • Suzhou Jinda Biological Engineering Co., Ltd.
  • Hebei Haobo Biological Technology Co., Ltd.
  • Fortune Bioproducts Co., Ltd.
  • Advanced Protein Technologies Pte Ltd.